Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,242 | 491 | 97.8% |
| Gift | $157.82 | 8 | 1.1% |
| Education | $101.47 | 2 | 0.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $68.44 | 4 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| EISAI INC. | $2,312 | 68 | $0 (2022) |
| ABBVIE INC. | $1,712 | 72 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $1,146 | 39 | $0 (2022) |
| ACADIA Pharmaceuticals Inc | $1,131 | 22 | $0 (2023) |
| UCB, Inc. | $1,053 | 49 | $0 (2024) |
| Avanir Pharmaceuticals, Inc. | $992.26 | 38 | $0 (2022) |
| Amgen Inc. | $872.97 | 22 | $0 (2022) |
| SK Life Science, Inc. | $602.49 | 10 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $559.85 | 17 | $0 (2024) |
| Lilly USA, LLC | $558.24 | 19 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $859.96 | 30 | ABBVIE INC. ($351.49) |
| 2023 | $1,497 | 55 | ABBVIE INC. ($702.70) |
| 2022 | $2,727 | 82 | ACADIA Pharmaceuticals Inc ($868.18) |
| 2021 | $1,895 | 85 | Eisai Inc. ($306.12) |
| 2020 | $1,109 | 47 | Teva Pharmaceuticals USA, Inc. ($219.92) |
| 2019 | $2,281 | 79 | EISAI INC. ($609.13) |
| 2018 | $1,905 | 56 | Eisai Inc. ($542.15) |
| 2017 | $2,295 | 71 | Eisai Inc. ($512.62) |
All Payment Transactions
505 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $23.99 | General |
| Category: NEUROSCIENCE | ||||||
| 10/07/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: PSYCHIATRY | ||||||
| 09/30/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $26.60 | General |
| Category: NEUROSCIENCE | ||||||
| 09/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $31.45 | General |
| Category: NEUROSCIENCE | ||||||
| 09/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: NEUROSCIENCE | ||||||
| 08/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: NEUROSCIENCE | ||||||
| 08/06/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: NEUROSCIENCE | ||||||
| 07/30/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: NEUROSCIENCE | ||||||
| 06/26/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: PSYCHIATRY | ||||||
| 06/26/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $23.34 | General |
| Category: NEUROSCIENCE | ||||||
| 06/26/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $9.44 | General |
| Category: NEUROSCIENCE | ||||||
| 06/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.05 | General |
| Category: NEUROSCIENCE | ||||||
| 06/17/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: PSYCHIATRY | ||||||
| 06/04/2024 | PROTEGA PHARMACEUTIALS INC | ROXYBOND (Drug) | Food and Beverage | In-kind items and services | $22.49 | General |
| Category: Pain Management | ||||||
| 05/23/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Neurology | ||||||
| 05/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: NEUROSCIENCE | ||||||
| 05/06/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: NEUROSCIENCE | ||||||
| 04/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: NEUROSCIENCE | ||||||
| 04/11/2024 | Otsuka America Pharmaceutical, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: NEUROLOGY | ||||||
| 04/08/2024 | PROTEGA PHARMACEUTIALS INC | ROXYBOND (Drug) | Food and Beverage | In-kind items and services | $23.16 | General |
| Category: Pain Management | ||||||
| 04/04/2024 | Lilly USA, LLC | AMYVID (Drug) | Food and Beverage | In-kind items and services | $23.20 | General |
| Category: Neuroscience | ||||||
| 04/01/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $28.27 | General |
| Category: PSYCHIATRY | ||||||
| 03/28/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $25.12 | General |
| Category: NEUROSCIENCE | ||||||
| 03/26/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $24.71 | General |
| Category: Neurology | ||||||
| 03/18/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $23.42 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,198 | 1,890 | $472,787 | $234,877 |
| 2022 | 15 | 1,523 | 2,624 | $582,425 | $287,554 |
| 2021 | 9 | 1,102 | 1,529 | $358,274 | $216,223 |
| 2020 | 8 | 1,137 | 1,556 | $338,698 | $212,741 |
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 361 | 781 | $156,150 | $78,121 | 50.0% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2023 | 128 | 130 | $65,000 | $50,684 | 78.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 196 | 196 | $58,800 | $38,571 | 65.6% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 128 | 129 | $38,650 | $22,907 | 59.3% |
| 93888 | Ultrasound of within the brain blood flow | Office | 2023 | 127 | 128 | $40,940 | $15,390 | 37.6% |
| 92653 | Evaluation of brain response to sound for diagnosis of nervous system disorders with interpretation and report | Office | 2023 | 128 | 129 | $38,700 | $9,660 | 25.0% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 28 | 102 | $15,300 | $4,426 | 28.9% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 26 | 98 | $11,760 | $3,389 | 28.8% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 16 | 52 | $7,800 | $2,816 | 36.1% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 18 | 55 | $27,500 | $2,398 | 8.7% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 14 | 26 | $4,602 | $2,350 | 51.1% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 13 | 13 | $3,760 | $2,111 | 56.2% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 15 | 51 | $3,825 | $2,054 | 53.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 364 | 838 | $167,350 | $82,199 | 49.1% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2022 | 145 | 145 | $72,500 | $56,699 | 78.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 199 | 199 | $59,650 | $40,426 | 67.8% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2022 | 143 | 143 | $42,800 | $27,521 | 64.3% |
| 93888 | Ultrasound of within the brain blood flow | Office | 2022 | 143 | 143 | $45,720 | $17,365 | 38.0% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2022 | 99 | 287 | $43,050 | $13,413 | 31.2% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 71 | 220 | $33,000 | $13,007 | 39.4% |
| 92653 | Evaluation of brain response to sound for diagnosis of nervous system disorders with interpretation and report | Office | 2022 | 144 | 144 | $43,200 | $11,480 | 26.6% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2022 | 54 | 171 | $20,520 | $6,476 | 31.6% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 43 | 131 | $9,825 | $5,823 | 59.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 47 | 96 | $12,025 | $4,041 | 33.6% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 20 | 40 | $6,000 | $3,550 | 59.2% |
About Dr. Irving Friedman, MD
Dr. Irving Friedman, MD is a Specialist healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1982783700.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Irving Friedman, MD has received a total of $14,569 in payments from pharmaceutical and medical device companies, with $859.96 received in 2024. These payments were reported across 505 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($14,242).
As a Medicare-enrolled provider, Friedman has provided services to 4,960 Medicare beneficiaries, totaling 7,599 services with total Medicare billing of $951,395. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Location Brooklyn, NY
- Active Since 11/03/2006
- Last Updated 03/24/2025
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1982783700
Products in Payments
- Fycompa (Drug) $2,312
- NUPLAZID (Drug) $1,131
- NUEDEXTA (Drug) $1,080
- VRAYLAR (Drug) $889.53
- Aimovig (Biological) $794.70
- Briviact (Drug) $620.57
- Equetro (Drug) $529.82
- XCOPRI (Drug) $482.15
- UBRELVY (Drug) $471.37
- QULIPTA (Drug) $450.01
- Vimpat (Drug) $432.50
- AJOVY (Biological) $382.74
- EMGALITY (Drug) $380.05
- AJOVY (Drug) $345.67
- AUSTEDO (Drug) $323.91
- REXULTI (Drug) $260.76
- VALTOCO (Drug) $223.98
- MOVANTIK (Drug) $158.77
- Gamunex-C (Biological) $145.05
- Xtampza ER (Drug) $132.78
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Brooklyn
Idan Sharon, M.d, M.D
Specialist — Payments: $2.3M
Dr. Sean Studer, M.d, M.D
Specialist — Payments: $411,591
Dr. Michael Lewis, M.d, M.D
Specialist — Payments: $68,268
Dr. Marc Avram, Md, MD
Specialist — Payments: $48,018
Michael Amoashiy, Md, MD
Specialist — Payments: $41,408
Dr. Madhavi Reddy, M.d, M.D
Specialist — Payments: $40,649